PedAM
Pediatric Disease Annotations & Medicines
| Disease | vascular disease |
| Phenotype | |diabetes |
| Sentences | 529 |
| PubMedID- 24259900 | Type 2 diabetes belongsto a group of diseases (cardiovascular diseases, alzheimer's disease, cancer, etc.) |
| PubMedID- 24918095 | Background: dyslipidemia is one of the major risk factors for cardiovascular disease in diabetes mellitus. |
| PubMedID- 25227555 | Impact of chronic kidney disease on the prevalence of cardiovascular disease in patients with type 2 diabetes in spain: percedime2 study. |
| PubMedID- 23738538 | Among people with diabetes, the highest risk of death from cardiovascular disease is found in those treated with oral hypoglycemic drugs or insulin [1,2] and in those with longer duration of diabetes [3-6]. |
| PubMedID- 26312908 | Interpretation: this study suggests that associations of type 2 diabetes vary with different incident cardiovascular diseases. |
| PubMedID- 21468921 | To confirm the efficacy of metformin use on triglyceride level and hdl-c level associated with the risk of cardiovascular disease in patient with diabetes, further placebo-controlled investigations are required. |
| PubMedID- 24782916 | This association is worrying because diabetes doubles the risk of cardiovascular disease and cardiovascular deaths account for about 50% of deaths in people with diabetes [7]. |
| PubMedID- 20186491 | We then discuss the implications of these studies for current management and for new approaches for the prevention and treatment of cardiovascular disease in patients with diabetes mellitus. |
| PubMedID- 26199685 | Background: diabetes is associated with increased cardiovascular disease, mortality and morbidity. |
| PubMedID- 21654912 | From as early as the 1970s, the world health organization multicentre vascular disease in diabetes survey demonstrated the propensity of asian populations to develop stroke and end-stage renal disease (esrd) whereas whites were more likely to develop chd [20]. |
| PubMedID- 26382729 | While previous studies have documented the burden of vascular disease in people with diabetes, to date no study has focussed on the impact of type 2 diabetes on the whole body atheroma burden combining quantitative of both wb-mra and cmr. |
| PubMedID- 22985021 | Aim: to examine how diabetes in combination with cardiovascular diseases (hypertension, heart disease and stroke) and geriatric conditions (cognitive impairment and depressive symptoms) affects the odds of disability in older adults. |
| PubMedID- 23162979 | diabetes screening as part of a vascular disease risk management programme. |
| PubMedID- 21270199 | Thus, ages may explain, in part, the increased cardiovascular disease and mortality attributable to type 1 diabetes and constitute a specific target for treatment in these patients. |
| PubMedID- 22860025 | All these observations show that individuals with ifg have higher risk for conversion to diabetes, development of atherosclerosis and cardiovascular diseases in future. |
| PubMedID- 24396696 | Pwv reflects arterial stiffness and is a marker of atherosclerotic vascular disease in patients with diabetes [44]. |
| PubMedID- 22422191 | Mortality of cardiovascular diseases in patients with type 1 diabetes is increased 2- to 20-fold compared to non-diabetic individuals. |
| PubMedID- 26223257 | The incidence of cardiovascular disease in people with diabetes is more than double that in people without diabetes, and the mortality rate after a first myocardial infarction is much higher in people with diabetes [2, 3]. |
| PubMedID- 19925460 | We present a case of brutal diabetes mellitus in a patient with severe vascular disease that underwent a third pancreas transplant. |
| PubMedID- 21404226 | Kidney function and mortality in different cardiovascular diseases: relationship with age, sex, diabetes and hypertension. |
| PubMedID- 21736687 | Reducing cardiovascular disease risk in patients with type 2 diabetes and concomitant macrovascular disease: can insulin be too much of a good thing. |
| PubMedID- 24855344 | Several large-scale, prospective, randomized trials have documented that lowering glycemic levels can prevent the development of microvascular disease in people with type 2 diabetes mellitus (t2dm). |
| PubMedID- 23951331 | This prospective cohort study demonstrates the value of ldl particle size measurements in the prediction of changes in metabolic status and cardiovascular disease in patients with diabetes or prediabetes. |
| PubMedID- 21933841 | Purpose: to evaluate myocardial microvascular disease in patients with type 2 diabetes mellitus (dm) using myocardial contrast echocardiography (mce) and to report on its diagnostic accuracy using single photon emission tomography (spect) as reference test. |
| PubMedID- 22234950 | Sub-optimal achievement of guideline-derived lipid goals in management of diabetes patients with atherosclerotic cardiovascular disease, despite high use of evidence-based therapies. |
| PubMedID- 20467927 | Results of recent large-scale intervention trials, such as accord, advance, and vadt, seem to undermine the concept that tight glycemic control confers some protection against cardiovascular disease in patients with type 2 diabetes, while maintenance of near-normal glycemic control from earlier stage of the disease and during acute coronary events seems to be more beneficial. |
| PubMedID- 23715361 | The present studies found that microalbuminuria is predictive, independent of classical risk factor of cardiovascular diseases and all causes of mortality in diabetes or hypertension patient groups and in the general population. |
| PubMedID- 21144031 | Risk factors with weaker and inconsistent associations were gender, ethnicity, diabetes, iris colour, history of cerebrovascular disease, and serum total and hdl cholesterol and triglyceride levels. |
| PubMedID- 22440125 | Microalbuminuria is one of the strongest predictors of both adverse renal and cardiovascular disease (cvd) outcomes in patients with type 2 diabetes mellitus. |
| PubMedID- 25898207 | The atherosclerosis of large vessels is associated with macrovascular diseases in diabetes, which result in coronary artery diseases, stroke, and peripheral vascular diseases [2]. |
| PubMedID- 22850257 | Hazard ratio (hr) with 95% confidence interval (ci) for the elderly diabetes associated with cardiovascular disease (cvd), hip fracture, and lower extremity amputation was 1.13 (1.04-1.23), 1.10 (0.91-1.34), and 1.25 (0.95-1.65), respectively. |
| PubMedID- 24903023 | Obesity and overweight are associated with comorbidities such as type ii diabetes, various types of cancer and cardiovascular diseases [26, 27], conditions that may contribute to reducing individual ability to work [16, 28–34]. |
| PubMedID- 20622162 | It certainly may be that this rapid aging of apoa-1, a key protein in lipoprotein metabolism, causes the known higher risk for macrovascular disease in people with type 1 diabetes (20). |
| PubMedID- 23841986 | Patients with diabetes are at risk of macrovascular and microvascular disease [7,8]. |
| PubMedID- 24920930 | Importance of cardiovascular disease risk management in patients with type 2 diabetes mellitus. |
| PubMedID- 21088641 | All had a history of diabetes mellitus with peripheral vascular disease. |
| PubMedID- 26060511 | [30] (2006)patients with diabetes free of vascular disease, receiving repaglinide or glibenclamide; italy12-month trial on glycemic control156mean 74 ± 2 yearsvariation in post-prandial blood glucose, fasting plasma glucose, and hba1c. |
| PubMedID- 25913343 | The miami healthy heart initiative is a randomized control trial designed to examine the effectiveness of chws on reducing the risk for cardiovascular disease among hispanics with poorly controlled diabetes in south florida. |
| PubMedID- 23130125 | Furthermore, we found a positive association between diabetes and other types of vascular disease in the same individuals. |
| PubMedID- 20967275 | For example, chronic hypertension is primarily characterized by endothelial dysfunction and microvascular disease whereas with diabetes the pathology may be due to direct effects of hyperglycemia in addition to vascular disease. |
| PubMedID- 25887356 | Objective: despite its growing prevalence in china, the extent to which diabetes leads to excess cardiovascular disease (cvd) mortality and all-cause mortality is unclear. |
| PubMedID- 20228404 | Background: we investigated whether combination therapy with a statin plus a fibrate, as compared with statin monotherapy, would reduce the risk of cardiovascular disease in patients with type 2 diabetes mellitus who were at high risk for cardiovascular disease. |
| PubMedID- 25288671 | We hypothesized that preexisting brain microvascular disease in patients with diabetes might partly explain increased stroke severity and impact on outcome. |
| PubMedID- 25238222 | What is it about very low density lipoproteins (vldl) and cardiovascular disease in patients with type 2 diabetes mellitus: is it the triglycerides or the cholesterol. |
| PubMedID- 23360385 | Previous studies have shown that morbidity and mortality from cardiovascular disease among adults with diabetes have declined in the united states [20,21]. |
| PubMedID- 20920271 | However, with the occurrence of dysfunction, the endothelium is a potential contributor to the pathogenesis of vascular disease in diabetes mellitus and atherosclerosis [12]. |
| PubMedID- 23185656 | The patients with diabetes, dyslipidemia, history of cardiovascular disease (coronary artery disease, congestive heart failure, stroke, transient ischemic attack or intermittent claudication) and carotid artery stenosis were excluded. |
| PubMedID- 22807666 | Impaired ca leads to more dependence of cbf on bp, leaving brain tissue unprotected against the potentially harmful effects of bp fluctuations, as demonstrated in cerebromicrovascular disease associated with diabetes [8]–[10], or after ischemic stroke [11]–[14] and brain injury [15]–[17]. |
| PubMedID- 21411509 | A mild-to-moderate reduction of egfr predicts cardiovascular disease in patients with type 2 diabetes, also independently of classic risk factors (24). |
| PubMedID- 24427312 | Post hoc analysis from the prospective pioglitazone clinical trial in macrovascular events (proactive) investigated the relationship between chronic kidney disease and the incidence of cardiovascular disease in patients with diabetes and documented macrovascular disease, as well as the effects of pioglitazone treatment on recurrent cardiovascular disease, and found that pioglitazone was more effective than placebo in reducing the rate of both primary and secondary composite end points in the patients with chronic kidney disease. |